• Puff - Recherche d'allergènes


    Rechercher les allergènes et les composants allergènes ImmunoCAP. Toutes les informations sont en anglais.

Code: i71
Latin name: Aedes communis
Source material: Whole insect
Family: Culicidae
Common names: Snow mosquito, woodland floodwater mosquito


An insect, which may result in allergy symptoms in sensitised individuals.

Allergen Exposure

The mosquitoes are a family of small, midge-like flies. A few species are harmless or even useful to humanity. However, most consume blood from living vertebrates, including humans. Various species of mosquitoes (and in particular, the females) act as vectors for a range of diseases, and transmit some of the most harmful human and livestock diseases. Mosquito habits differ; even among those that do carry important diseases, not all species carry the same diseases, or carry them under the same circumstances. Others do not routinely bite humans, but are the vectors for animal diseases.

Mosquitoes are members of the family Culicidae (stinging mosquitoes). There are more than 40 mosquito genera and more than 3 500 mosquito species worldwide. Three common mosquito species occurring globally are Culex quinquefasciatus (southern house mosquito), Aedes aegypti, and Anopheles stephensi. (1) Aedes communis is found over almost all of Europe, and in North America, Asia and Japan.

The genus Aedes contains more than 500 species distributed from the polar regions to the tropics, including North America and Europe. (2)

Aedes aegypti is the most important mosquito pest in the world, and shares many salivary allergens with other species including Culex quinquefasciatus, and with Aedes vexans, another common pest mosquito indigenous to North America. (3, 4, 5)

Mosquitoes go through four stages in their life cycle: egg, larva, pupa, and adult. In most species, adult females lay their eggs in standing water; some lay eggs near the water's edge; others attach their eggs to aquatic plants. The first three stages (egg, larva and pupa) are mostly aquatic. These stages typically last 5-14 days, depending on the species and the ambient temperature. (6) Eggs hatch to become larvae, which grow until they are able to change into pupae. The adult mosquito emerges from the mature pupa as it floats at the water’s surface. Bloodsucking mosquitoes have potential adult lifespans ranging from as little as a week to as long as several months, depending on species, gender, and weather conditions.

Species of Aedes characteristically lay their eggs either singly on the ground, on the waterline, or slightly above the waterline in tree holes or containers. These eggs hatch after flooding, and in some species they are able to survive long periods of drying. Some species have only one brood a year. Their eggs do not hatch until they have been subjected to periods of drying or cold. Other species are intermittent breeders and have several generations per year depending on rainfall or irrigation practices. Aedes species occurring in regions with cold winters pass the winter in the egg stage. (2)

Larval habitats of Aedes are extremely variable. In general, they are found in temporary pools formed by rains, melting snow, or overflows. Some species occur in coastal salt marshes that are flooded at intervals by unusually high tides. Others have become adapted to irrigation practices. A few species occur in tree holes, rock pools, and artificial containers. Practically all species of Aedes are blood-sucking. Biting habits may vary, but they attack most frequently during evening hours. However, some species bite only during the day; others bite by day or by night. (2)

The mosquito, as with all blood-feeding arthropods, has mechanisms to effectively block the haemostasis system with their saliva, which is composed of a mixture of secreted proteins. Mosquito saliva usually contains fewer than 20 dominant proteins. (7)

Allergen Description

Mosquito saliva contains many biological materials which may be classified according to their functions, as follows: (a) anticlotting and antiplatelet factors and vasodilators; (8, 9) (b) substances that affect parasite transmission by arthropod vectors; (3, 10) (c) enzymes associated with sugar feeding; (3, 11) (d) lysozyme, which may help to control bacterial growth in the meal stored in the mosquito’s crop; (12) and (e) immunomodulators. (13, 14) Most of these substances in mosquito saliva have been identified as allergens. (4, 15, 16)

Most of the proteins in mosquito saliva are allergenic in humans. (4, 16, 17, 18, 19, 20, 21) Up to 19 allergens have been found in mosquito salivary gland extracts, with molecular masses ranging from 16 to 95 kDa, (4, 18) and at least 8 proteins in the saliva of Aedes aegypti have been identified as allergens which bind to the IgE of individuals who have large local allergic reactions to mosquito bites. (4) Both species-shared and species-specific allergens exist. Among the 10 species of mosquito studied, Aedes albopictus saliva contains at least 16 allergens, Aedes vexans 12 allergens, and Aedes aegypti and Culex quinquefasciatus 8-9 allergens. (3, 4)

Limited studies have been conducted on allergens from Aedes communis, hence inference from studies on other species is in order.

In a recent study saliva-specific IgE to 5 mosquito species were measured in serum of 14 individuals who had systemic reactions to mosquito bites. (47) Eleven of these individuals had a positive IgE response to Aedes albopictus saliva, a species which was previously reported to contain the highest number of allergens of 10 species studied, (4) while 5-8 individuals had raised serum-specific IgE to saliva from each of the remaining 4 species (Aedes vexans, Aedes aegypti, Culex quinquefasciatus and Anopheles sinornata), suggesting that Aedes albopictus has the highest number of species-shared allergens. IgE antibodies against 35.5, 32.5, and 22.5 kDa allergens in Culex quinquefasciatus saliva were found in 22 (41%), 15 (28%), and 13 (24%) respectively of 54 individuals with a history of mosquito bite allergy. The 22.5 kDa allergen was found mainly in children. (22) It is therefore apparent that a heterogenous response to allergens in the population can be expected, which may differ between age groups.

Although the common cause of hypersensitivity reactions is as a result of ‘mosquito bites’, mosquito-derived allergens and/or fragments which are present in air might serve as important inhalant allergens in type-I allergic respiratory disorders. (1, 23, 24, 25)

Immunoblot analysis showed unique individual IgE-binding patterns and suggested that both genus- and species-specific mosquito allergens exist. (26)

Four proteins in the saliva of A. communis with molecular weights of 22, 30, 36, and 64 kDa have been found to be antigenic by immunoblotting studies. (21) The most frequent IgE binding has been reported to occur to the 36 kDa protein, (21) although most people with immediate skin reactivity to A. communis mosquito bites have IgE that recognise the 36 kDa and 22 kDa antigens. (21, 27) The response to the 36 kDa antigen appears to be shared with A. aegypti. (17) A 37 kDa major antigen protein was isolated and cloned (28) from the adult female salivary glands of A. aegypti and appears to be shared by Aedes species distributed world-wide, (5) and perhaps also by other Diptera species. Another protein, Aed a 1, a 68 kD apyrase, has also been characterised as an important allergen in the saliva of Aedes aegypti. (29)

No allergens from A. communis have been characterised. However, a range of proteins and allergens have been isolated and characterised from A. aegypti, and may be representative of those in A. communis.

Table. Aedes aegypti salivary proteins

Protein name

Allergen name

Molecular weight (kDa)

Biological functions


alpha-Amylase 1






Aed a 1



(3, 30, 31)

alpha-Glucosidase (maltase-like 1)

Aed a 4


Sugar digestion

(3, 30)






Anticoagulant-factor Xa





Aed a X1

Aed a X1 ?




Aed a X2

Aed a X2 ?




Female-specific protein, D7

Aed a 2



(3, 30, 32)


Aed a 3



(3, 30, 33)






Antitumour necrosis factor










Modified from Peng and Simons (30)


Potential Cross-Reactivity

Cross-reactivity within the family Culicidae seems to be extensive, and there may be a certain degree of cross-reactivity with other families. Cross-reactivity with Anopheles (malaria) mosquito has been shown. (34)

That species-specific and cross-reactive allergens are present is illustrated by a study that demonstrated that an allergen similar to Aed a 2 of A. aegypti was found in 7 of the 11 mosquito species studied (Ochlerotatus triseriatus, Culex quinquefasciatus, and all five Aedes species (A. communis, A. aegypti, A. vexans, A. albopictus, A. togoi), but not in the remaining four species (Culex pipiens, Culex tarsalis, Anopheles sinensis and Culiseta inornata). The data indicated that the proteins in other mosquito species, especially in the Aedes genus, share common antigenic structures with Aed a 1 and Aed a 2 of A. aegypti. The authors suggested that Aed a 4, an alpha-glucosidase, may also be a cross-reactive allergen, since alpha-glucosidase was found in other mosquito species. (3)

Cross-reactivity has been demonstrated between C. quinquefasciatus, A. aegypti and A stephensi, with evidence that 30 and 33 kDa proteins are shared among these 3 mosquitos. (1)

Mosquito salivary allergens may cross-react with allergens from other biting insects (chironomids) and from crustaceans. (35, 36, 37, 38, 39) Moreover, there are rare reports of cross-reactivity with allergens in Hymenoptera venom, attributed to the presence of hyaluronidase. (40, 41)

Appreciating which allergens are cross-reactive may influence diagnoses, as illustrated by a study which detected a 25 kDa protein in the serum of a 14-year-old boy with seasonal rhinoconjunctivitis and an immediate local reaction to a mosquito bite. He had raised serum IgE to a number of arthropod species, including Chironomus thummi (3.2 kU/l), A. communis (12.7kU/l), D. pteronyssinus (3.2 kU/l); yet he had had no contact with chironomids and was asymptomatic outside springtime. Immunoblot testing demonstrated that a similar 25 kDa protein was present in all three, postulated to be a glutathione S-transferase enzyme. (42) This was similarly alluded to in a second study by the same authors, (38) who also reported a patient who demonstrated cross-reactivity between A. communis, Culex pipiens and red midge larvae (Chironomus). (43)

A Spanish study reported that 31% of patients with reactions to mosquito bite were sensitised to A. communis, and 53% of this group were also sensitised to other arthropods, probably due to cross-reactivity. (44)

Clinical Experience

a. IgE-mediated reactions

Throughout the world, allergic reactions to mosquito bites are of clinical concern. Reactions may vary from being mild, and simply a skin irritation, to local allergic reactions, but may also result in life-threatening reactions. (23, 24, 25, 30, 45) Although cutaneous reactions are seen most often, systemic reactions, including generalised urticaria and angioedema have been reported. (46, 47, 48, 49, 50) Severe local reactions such as ‘Skeeter Syndrome’ have also been described. (51) Respiratory allergy, including rhinitis, conjunctivitis, and/or asthma (caused by inhalation of mosquito fragments containing allergens), has been reported. (23)

Mosquito bite-sensitive subjects frequently have circulating IgE and IgG4 antibodies to Aedes mosquito saliva proteins. (19, 21, 26, 27, 52) Typically the levels are highest in children, and slowly decrease over time. (53) However, IgE-mediated and T-lymphocyte-mediated hypersensitivities are involved in the development of mosquito allergy. (5, 19, 21, 46, 54, 55) A study on people living in Finnish Lapland revealed that seasonal exposure to mosquito bites leads to an increased IgE, IgG4 and IgG1 antibody response, a phenomenon similar to that occurring in (for example) pollen allergy. (56)

Cutaneous reactions following mosquito bites range from immediate wheal-and-flare reactions to delayed bite papules. Typical local cutaneous reactions to mosquito bites consist of small immediate wheals and flares peaking at 20 minutes, and delayed pruritic indurated papules peaking at 24-36 hours, then diminishing over several days or weeks. (52, 57) Large local reactions to mosquito bites consist of itchy, red, warm swellings appearing within minutes of the bites, and itchy papules and ecchymotic, vesiculated, blistering, bullous, haemorrhagic or even Arthus reactions, appearing 2-6 hours after the bites and persisting for days or weeks. (51, 58, 59, 60, 61, 62) Only those reactions which cause large or atypical (ecchymotic or vesiculated) local reactions or systemic reactions are considered to be ‘mosquito allergy’. (3)

A study of 14 individuals with a history of acute systemic allergic reactions to mosquito bites – defined as the presence of one or more of the following: urticaria, angioedema, wheezing, dyspnea, hypotension, and decrease or loss of consciousness – is illustrative. Ten individuals were from the United States and one each from Canada, Germany, Japan, and Switzerland. Testing was conducted for specific IgE and IgG antibodies to saliva from 5 common mosquito species with different geographic distributions: mosquito saliva-specific IgE levels to all 5 species were significantly increased in the individuals with systemic allergic reactions, compared with the control subjects. 11 individuals had positive results to A. albopictus and up to 4 additional species; 3 individuals had positive results to only one species. (47)

Individuals at increased risk of severe reactions to mosquito bites include those with: a) a high level of exposure, for example, outdoor workers; (46) b) weak natural immunity, for example, infants and young children; (51, 63) c) no previous exposure to indigenous mosquitoes, for example, immigrants or visitors; and d) primary or secondary immune deficiency such as AIDS, malignancies (64) or Epstein-Barr virus-associated lymphoproliferative diseases. (30, 65) However, severe anaphylactic reactions to mosquito stings are surprisingly rare with regard to the worldwide distribution of mosquitos. (4) Possibly, naturally-acquired immunity by repeated exposure is crucial. (53, 57)

‘Skeeter Syndrome’ is defined as a mosquito-induced large local inflammatory reaction sometimes accompanied by low-grade fever that is often misdiagnosed as cellulitis. Systemic reactions following mosquito bites include angioedema, generalised urticaria, nausea, vomiting, wheezing and other anaphylaxis manifestations. (23, 35, 40, 46, 47)

Clinical observations of the natural history of sensitisation and subsequent desensitisation to the saliva injected by mosquito bites have been classified into five stages. (66 cited in 3, 67 cited in 3) Individuals who have never been exposed to a specific species of mosquito do not get a reaction from the initial bites (stage I), but following subsequent bites, delayed cutaneous lesions appear (stage II). After repeated bites, immediate wheals develop (stage III). With further exposure, delayed reactions are no longer observed, and only immediate wheals are noted (stage IV). Individuals repeatedly exposed to thousands of bites from the same species of mosquito eventually lose the immediate reactions (stage V). These 5 stages have also been documented in a study in which stages II and IV appeared to be transient. (57)

Naturally-acquired desensitisation to mosquito saliva has also been confirmed in several cross-sectional studies. (3) Indeed, immunotherapy using injections of mosquito whole-body extracts has been reported to prevent allergic reactions to subsequent bites. (46, 60, 68)

As a result of species-specific and common allergens, diagnosis may be problematical; as illustrated in the case report of a 19-year-old man who presented with persistent pruriginous lesions several hours after being bitten by a mosquito. Prick tests to commercial extract of whole-body extracts (Culex pipiens) were negative; however, the intradermal test was positive. Specific mosquito (A. communis) IgEs were raised (1.06 kIU/L). Specific immunotherapy with a whole-body extract of C. pipiens was successful. (69) The basophil activation test has been successfully utilised in certain instances. (48)

The relevance of species-specific and common allergens is also illustrated by a study evaluating the prevalence of IgE and IgG4 class antibodies to the saliva of A. communis and A. aegypti mosquitoes in the sera of three groups of exposed children. The frequencies of IgE antibodies to the major 36 kDa A. communis and A. aegypti saliva antigens ranged from 82 to 90% in the 20 Finnish, 17 Kenyan, and 20 Mexican children. The corresponding IgG4 antibody frequencies were 85, 41, and 20%, respectively. The Finnish children abnormally sensitive to mosquito bites frequently had IgE and IgG4 antibodies to the 22 kDa A. communis saliva antigen, suggesting that these antibodies play a role in the pathogenesis of immediate cutaneous mosquito bite reactions. In contrast to this, no increase was found in the frequency of A. aegypti antibody in the Kenyan and Mexican children with papular urticaria, suggesting that humoral immune response to A. aegypti saliva was not involved in the development of this disorder. (27)

Cutaneous reactivity to mosquito bites was examined in 27 adult volunteers exposed to A. communis mosquitoes. Twenty-three subjects experienced a combination of immediate whealing and delayed bite-papules, two subjects each experienced only immediate or delayed cutaneous reactions, and two were non-responsive to the bites. The mean size of whealing and the mean score of pruritus was similar in 19 non-atopic and in eight atopic volunteers. The authors concluded that the results confirmed that normal subjects exhibit different stages of sensitisation to mosquito bites. (70)

A girl aged 14 years, who showed local skin lesions and generalised reactions such as fever, hepatosplenomegaly, hypergammaglobulinaemia and pancytopenia following mosquito bites, was shown to have specific IgE antibody against mosquito antigens after being evaluated with various immunological methods. (24)

Although mosquito allergy has been reported world-wide, few prevalence studies have been conducted.

A cross-sectional descriptive study of children from 11 public elementary schools in the metropolitan area of Monterrey, Mexico, reported that 76% of respondents had experienced adverse effects to mosquito bite in the preceding 12 months, of which itching (75%) and rash (72%) were the most frequent symptoms. (71)

An Indian study evaluating 3 389 consecutive patients attending an allergy clinic over a period of 5 years found that around 58% of children and 60% of adults were skin-prick test-positive for mosquito (species not specified). (72)

Cross-reactivity may play a role in prevalence studies. In previous studies conducted on young adults in Reykjavik, Iceland, 6-9% were shown to be sensitised to house dust mite Dermatophagoides pteronyssinus. However, only negligible amounts of HDM and HDM allergens were detected in their homes. Of those with specific IgE against D. pteronyssinus, 75% had detectable IgE antibodies to cross-reactive allergens, compared with none in the control group: Lepidoglyphus destructor (67%), shrimp (58%), cockroach (33%), mosquito (17%), tropomyosin (17%) and blood worm (4%). (73)

Similarly, a skin-prick study of 131 Taiwanese patients found that 71% had positive skin reactions to D pteronyssinus, 69% to D. farinae, 44% to Blomia tropicalis, 37% to American cockroach, 36% to German cockroach, 4% to dog dander, 8% to cat dander, and 29% to mosquito (species not specified). (74)

A study of 100 Norwegian families (426 subjects) of 7- to 35-year-old sibling-pairs with asthma and their parents, evaluated for sensitisation to common local inhalant allergens, reported that 31 subjects (7.5%) were sensitised (5 monosensitised) to cockroach (27 by skin-prick test and seven by IgE antibody, all with additional inhalant allergy), and co-sensitisation was most common to grass (in 61%), cat (48%), dog (48%) and mites (42%). Of the cockroach-sensitised patients, 5 were sensitised to mosquito (species not identified) compared to none of the 393 in the non-sensitised group. (75)

Authors have suggested, as commercially-available mosquito allergen preparations are made from whole-body extracts (which may contain little salivary protein and many non-salivary proteins), that these may cause new sensitisation and other side effects. (76) In a study, a serum-specific IgE test in which a mosquito whole-body extract was used as the capture antigen was compared to a mosquito saliva-capture ELISA in the diagnosis of individuals with systemic or severe local reactions to mosquito bites. (77) The mosquito saliva-capture ELISA was more sensitive and specific (less likely to give false-negative and false-positive results) than the serum-specific IgE assay in the diagnosis of mosquito allergy. The positivity rate was 56% for the saliva-capture ELISA and 25% for the serum-specific IgE test in mosquito-allergic individuals, versus 5% in the negative controls. The results suggest that mosquito saliva proteins should be used in the diagnosis of mosquito allergy. (3)

Immunotherapy using injections of mosquito whole-body extracts has been shown to prevent allergic reactions to subsequent bites. (46, 60, 68, 69) In a study of 20 mosquito-allergic individuals treated with A. communis whole-body extract for 18 months, the treated individuals reported the disappearance of severe local reactions and symptoms of allergic rhinitis, which was statistically correlated with improvement of symptom and medication consumption scores and decreased allergic reactivity in nasal provocation tests with mosquito extract. (68)

However, it has been suggested that because current commercially-available mosquito whole-body extracts contain few mosquito-saliva proteins and many non-salivary proteins, these may be ineffective in down-regulating the specific immune responses to mosquito salivary allergens and may cause additional sensitisation. (76) In the future, the production of recombinant allergens may facilitate diagnosis and desensitisation. (30, 33)

b. Other reactions

It has been suggested that hypersensitivity to mosquito bites is associated with chronic Epstein-Barr virus (EBV) infection and natural killer (NK) cell leukaemia/lymphoma. (78, 79)

A previously healthy 25-year-old female patient developed hypersensitivity pneumonitis following repeated exposure to the smoke of mosquito coils. (80)

Airline flights departing from certain locations, in particular where malaria is prominent, are fumigated with pyrethroids. Only anecdotal reports of adverse responses among passengers or crew have been received. A description of pyrethroid allergy in an individual exposed to this chemical is described. (81)

Compiled by Dr Harris Steinman,


  1. Kausar MA, Vijayan VK, Bansal SK, Menon BK, Vermani M, Agarwal MK. Mosquitoes as sources of inhalant allergens: Clinicoimmunologic and biochemical studies. J Allergy Clin Immunol 2007;120(5):1219-21.
  2. Pratt HD, Moore CG. Notes on important species of mosquitos. US Dept Health & Human Services 1993. Accessed June 2012.
  3. Peng Z, Estelle F, Simons R. Mosquito allergy and mosquito salivary allergens. Protein Pept Lett 2007;14(10):975-81.
  4. Peng Z, Li H, Simons FE. Immunoblot analysis of salivary allergens in 10 mosquito species with worldwide distribution and the human IgE responses to these allergens. J Allergy Clin Immunol 1998;101(4 Pt 1):498-505.
  5. Peng Z, Simons FE. Cross-reactivity of skin and serum specific IgE responses and allergen analysis for three mosquito species with worldwide distribution. J Allergy Clin Immunol 1997;100(2):192-8.
  6. Biological notes on mosquitoes. Accessed June 2012.
  7. Valenzuela JG, Pham VM, Garfield MK, Francischetti IM, Ribeiro JM. Toward a description of the sialome of the adult female mosquito Aedes aegypti. Insect Biochemistry and Molecular Biology 2002;32 (9):1101-22.
  8. Ribeiro JM. Role of saliva in blood-feeding by arthropods. Annu Rev Entomol 1987;32:463-78.
  9. Ribeiro JM. Blood-feeding arthropods: live syringes or invertebrate pharmacologists? Infect Agents Dis 1995;4(3):143-52.
  10. Valenzuela JG, Belkaid Y, Garfield MK, Mendez S, Kamhawi S, Rowton ED, Sacks DL, Ribeiro JM. Toward a defined anti-Leishmania vaccine targeting vector antigens: characterization of a protective salivary protein. J Exp Med 2001;194(3):331-42.
  11. Grossman GL, James AA. The salivary glands of the vector mosquito, Aedes aegypti, express a novel member of the amylase gene family. Insect Mol Biol 1993;1(4):223-32.
  12. Rossignol PA, Lueders AM. Bacteriolytic factor in the salivary glands of Aedes aegypti. Comp Biochem Physiol B 1986;83(4):819-22.
  13. Cross ML, Cupp EW, Enriquez FJ. Differential modulation of murine cellular immune responses by salivary gland extract of Aedes aegypti. Am J Trop Med Hyg 1994;51(5):690-6.
  14. Owhashi M, Harada M, Suguri S, Ohmae H, Ishii A. The role of saliva of Anopheles stephensi in inflammatory response: identification of a high molecular weight neutrophil chemotactic factor. Parasitol Res 2001;87(5):376-82.
  15. Malafronte Rdos S, Calvo E, James AA, Marinotti O. The major salivary gland antigens of Culex quinquefasciatus are D7-related proteins. Insect Biochem Mol Biol 2003;33(1):63-71.
  16. Jeon SH, Park JW, Lee BH. Characterization of human IgE and mouse IgG1 responses to allergens in three mosquito species by immunoblotting and ELISA. Int Arch Allergy Immunol 2001;126(3):206-12.
  17. Brummer-Korvenkontio H, Palosuo T, François G, Reunala T. Characterization of Aedes communis, Aedes aegypti and Anopheles stephensi mosquito saliva antigens by immunoblotting. Int Arch Allergy Immunol 1997;112(2):169-74.
  18. Penneys NS, Nayar JK, Bernstein H, Knight JW, Leonardi C. Mosquito salivary gland antigens identified by circulating human antibodies. Arch Dermatol 1989 Feb;125(2):219-22.
  19. Shen HD, Chen CC, Chang HN, Chang LY, Tu WC, Han SH. Human IgE and IgG antibodies to mosquito proteins detected by the immunoblot technique. Ann Allergy 1989;63(2):143-6.
  20. Shan EZ, Taniguchi Y, Shimizu M, Ando K, Chinzei Y, Suto C, Ohtaki T, Ohtaki N. Immunoglobulins specific to mosquito salivary gland proteins in the sera of persons with common or hypersensitive reactions to mosquito bites. J Dermatol 1995;22(6):411-8.
  21. Brummer-Korvenkontio H, Lappalainen P, Reunala T, Palosuo T. Detection of mosquito saliva-specific IgE and IgG4 antibodies by immunoblotting. J Allergy Clin Immunol 1994;93(3):551-5.
  22. Wongkamchai S, Techasintana P, Wisuthsarewong W, Kulthanan K, Suthipinittharm P, Eakpo P. Analysis of IgE-binding allergens in Culex quinquefasciatus saliva protein in mosquito bite allergic patients. Ann Allergy Asthma Immunol 2007;98(2):200-1.
  23. Gluck JC, Pacin MP. Asthma from mosquito bites: a case report. Ann Allergy 1986;56(6):492-3.
  24. Suzuki S, Negishi K, Tomizawa S, Shibasaki M, Kuroume T. A case of mosquito allergy. Immunological studies. Acta Allergol 1976;31(6):428-41.
  25. Lelong M, Bras C, Castelain C, Drain JP. Severe local reactions to mosquito bites. Apropos of 20 cases. [French] Allerg Immunol (Paris) 1986;18(9):19,21-2.
  26. Wu CH, Lan JL. Immunoblot analysis of allergens in crude mosquito extracts. Int Arch Allergy Appl Immunol 1989;90(3):271-3.
  27. Reunala T, Brummer-Korvenkontio H, Palosuo K, Miyanij M, Ruiz-Maldonado R, Löve A, François G, Palosuo T. Frequent occurrence of IgE and IgG4 antibodies against saliva of Aedes communis and Aedes aegypti mosquitoes in children. Int Arch Allergy Immunol 1994;104(4):366-71.
  28. James AA, Blackmer K, Marinotti O, Ghosn CR, Racioppi JV. Isolation and characterization of the gene expressing the major salivary gland protein of the female mosquito, Aedes aegypti. Mol Biochem Parasitol 1991;44(2):245-53.
  29. Xu W, Simons FE, Peng Z. Expression and rapid purification of an Aedes aegypti salivary allergen by a baculovirus system. Int Arch Allergy Immunol 1998;115(3):245-51.
  30. Peng Z, Simons FE. Mosquito allergy: immune mechanisms and recombinant salivary allergens. Int Arch Allergy Immunol 2004;133(2):198-209.
  31. Peng Z, Xu W, James AA, Lam H, Sun D, Cheng L, Simons FE. Expression, purification, characterization and clinical relevance of rAed a 1--a 68-kDa recombinant mosquito Aedes aegypti salivary allergen. Int Immunol 2001;13(12):1445-52.
  32. Peng Z, Xu W, Lam H, Cheng L, James AA, Simons FE. A new recombinant mosquito salivary allergen, rAed a 2: allergenicity, clinical relevance, and cross-reactivity. Allergy 2006;61(4):485-90.
  33. Simons FE, Peng Z. Mosquito allergy: recombinant mosquito salivary antigens for new diagnostic tests. Int Arch Allergy Immunol 2001;124(1-3):403-5.
  34. Simons FER, Peng Z. Mosqquito allergy. In: Levine MI, Lockey RF. Monograph on insect allergy. American Academy of Allergy Committee on Insects. Fourth Ed., 2003:175-203.
  35. Baldo BA, Panzani RC. Detection of IgE antibodies to a wide range of insect species in subjects with suspected inhalant allergies to insects. Int Arch Allergy Appl Immunol 1988;85(3):278-87.
  36. Panzani RC, Ariano R. Arthropods and invertebrates allergy (with the exclusion of mites): the concept of panallergy. Allergy 2001;56 Suppl 69:1-22.
  37. Eriksson NE, Ryden B, Jonsson P. Hypersensitivity to larvae of chironomids (non-biting midges). Cross-sensitization with crustaceans. Allergy 1989;44(5):305-13.
  38. Galindo PA, Lombardero M, Mur P, Feo F, Gomez E, Borja J, Garcia R, Barber D. Patterns of immunoglobulin E sensitization to chironomids in exposed and unexposed subjects. J Investig Allergol Clin Immunol 1999;9(2):117-22.
  39. Cabrerizo BS, De BM, Baeza ML, Rubio SM. Allergy to chironomid larvae (red midge larvae) in non professional handlers of fish food. J Investig Allergol Clin Immunol 2006;16(1):63-8.
  40. Sabbah A, Hassoun S, Drouet M, Lauret MG, Doucet M. The wasp/mosquito syndrome. [French] Allerg Immunol (Paris) 1999;31(6):175-84.
  41. Quercia O, Emiliani F, Foschi FG, Stefanini GF. The wasp-horsefly syndrome. Eur Ann Allergy Clin Immunol 2008;40(2):61-3.
  42. Galindo PA, Lombardero M, Borja J, Gómez E, Feo F, Barber D, García R. A new arthropod panallergen? Allergy 2001;56(2):195-7.
  43. Galindo PA, Gómez E, Borja J, Feo F, García R, Lombardero M, Barber D. Mosquito bite hypersensitivity. Allergol Immunopathol (Madr) 1998;26(5):251-4.
  44. Martínez-Molero MI. Round Table: Urticaria caused by arthropod bites and stings (excluding Hymenoptera). [Spanish] Allergol Immunopathol (Madr) 1999;27(2):96-104.
  45. Peng Z, Simons FE. Advances in mosquito allergy. Curr Opin Allergy Clin Immunol 2007 Aug;7(4):350-354.
  46. McCormack DR, Salata KF, Hershey JN, Carpenter GB, Engler RJ. Mosquito bite anaphylaxis: immunotherapy with whole body extracts. Ann Allergy Asthma Immunol 1995;74(1):39-44.
  47. Peng Z, Beckett AN, Engler RJ, Hoffman DR, Ott NL, Simons FE. Immune responses to mosquito saliva in 14 individuals with acute systemic allergic reactions to mosquito bites. J Allergy Clin Immunol 2004;114(5):1189-94.
  48. Hassoun S, Drouet M, Sabbah A. Anaphylaxis caused by a mosquito: 2 case reports. [French] Allerg Immunol (Paris) 1999;31(8):285-7.
  49. Eseverri JL, Cozzo M, Castillo M, Marin A. Round Table: Immunological urticaria mediated by IgE. [Spanish] Allergol Immunopathol (Madr) 1999;27(2):104-11.
  50. Sabbah A, Sainte-Laudy J, Hassoun S, Drouet M, Lauret MG, Loiry ML. Allergy to mosquitoes and use of new immunobiological parameters. [French] Allerg Immunol (Paris) 1997;29(5):126-8.
  51. Simons FER, Peng Z. Skeeter syndrome. Allergy Clin Immunol 1999;104:705-7.
  52. Peng Z, Yang M, Simons FE. Immunologic mechanisms in mosquito allergy: correlation of skin reactions with specific IgE and IgG antibodies and lymphocyte proliferation response to mosquito antigens. Ann Allergy Asthma Immunol 1996;77(3):238-44.
  53. Bircher AJ. Systemic immediate allergic reactions to arthropod stings and bites. Dermatology 2005;210(2):119-27.
  54. Viniaker H, Lavaud F. Mosquito bite allergy. [French] Revue francaise d allergologie 2005;45(8):620-5.
  55. Reunala T, Brummer-Korvenkontio H, Palosuo T. Are we really allergic to mosquito bites? Ann Med 1994;26(4):301-6.
  56. Palosuo K, Brummer-Korvenkontio H, Mikkola J, Sahi T, Reunala T. Seasonal increase in human IgE and IgG4 antisaliva antibodies to Aedes mosquito bites. Int Arch Allergy Immunol 1997;114(4):367-72.
  57. Peng Z, Simons FE. A prospective study of naturally acquired sensitization and subsequent desensitization to mosquito bites and concurrent antibody responses. J Allergy Clin Immunol 1998;101(2 Pt 1):284-6.
  58. Brown A, Griffitts THD, Erwin S. and Dyrenforth LY. Arthus's phenomenon from mosquito bites: Report of a case with experimental studies. S Med J 1938;31:590.
  59. Walker GB, Harrison PV. Seasonal bullous eruption due to mosquitoes. Clin Exp Dermatol 1985 Mar;10(2):127-32.
  60. Benaim-Pinto C, Fassrainer A. Intradermal immunotherapy in children with severe skin inflammatory reactions to Aedes aegypti and Culex quinquefasciatus mosquito bites. Int J Dermatol 1990;29(8):600-1.
  61. Reunala T, Brummer-Korvenkontio H, Räsänen L, François G, Palosuo T. Passive transfer of cutaneous mosquito-bite hypersensitivity by IgE anti-saliva antibodies. J Allergy Clin Immunol 1994;94(5):902-6.
  62. Engler RJ. Mosquito bite pathogenesis in necrotic skin reactors. Curr Opin Allergy Clin Immunol 2001;1:349-52.
  63. Peng Z, Ho MK, Li C, Simons FE. Evidence for natural desensitization to mosquito salivary allergens: mosquito saliva specific IgE and IgG levels in children. Ann Allergy Asthma Immunol 2004;93(6):553-6.
  64. Penneys NS, Nayar JK, Bernstein H, Knight JW. Chronic pruritic eruption in patients with acquired immunodeficiency syndrome associated with increased antibody titers to mosquito salivary gland antigens. J Am Acad Dermatol 1989;21(2 Pt 2):421-5.
  65. Satoh M, Oyama N, Akiba H, Ohtsuka M, Iwatsuki K, Kaneko F. Hypersensitivity to mosquito bites with natural-killer cell lymphocytosis: the possible implication of Epstein-Barr virus reactivation. Eur J Dermatol 2002;12(4):381-4.
  66. Mellanby K. Man's reaction to mosquito bites. Nature 1946;158(4016):554.
  67. McKiel JA, West AS. Nature and causation of insect bite reactions. Pediatr Clin North Am 1961;8795-814.
  68. Ariano R, Panzani RC. Efficacy and safety of specific immunotherapy to mosquito bites. Allerg Immunol (Paris) 2004;36(4):131-8.
  69. Beaudouin E, Kanny G, Renaudin JM, Moneret-Vautrin DA. Allergen-specific immunotherapy to mosquitoes. Allergy 2001;56(8):787.
  70. Reunala T, Lappalainen P, Brummer-Korvenkontio H, Coulie P, Palosuo T. Cutaneous reactivity to mosquito bites: effect of cetirizine and development of anti-mosquito antibodies. Clin Exp Allergy 1991;21(5):617-22.
  71. Manrique Lopez MA, Gonzalez Diaz SN, Arias CA, Sedo Mejia GA, Canseco Villarreal JI, Gomez Retamoza EA, Padron Lopez OM, Cruz Moreno MA, Cisneros Salazar GD. Adverse reactions to mosquito bites in scholars from Monterrey, Nuevo Leon, Mexico. [Spanish] Rev Alerg Mex 2010;57(3):79-84.
  72. Shaikh WA, Shaikh SW. Allergies in India: an analysis of 3389 patients attending an allergy clinic in Mumbai, India. J Indian Med Assoc 2008;106(4):220, 222, 224 passim.
  73. Adalsteinsdottir B, Sigurdardottir ST, Gislason T, Kristensen B, Gislason D. What characterizes house dust mite sensitive individuals in a house dust mite free community in Reykjavik, Iceland? Allergol Int 2007;56(1):51-6.
  74. Tsai JJ, Yi FC, Chua KY, Liu YH, Lee BW, Cheong N. Identification of the major allergenic components in Blomia tropicalis and the relevance of the specific IgE in asthmatic patients. Ann Allergy Asthma Immunol 2003;91(5):485-9.
  75. Lødrup Carlsen KC, Carlsen KH, Buchmann MS, Wikstrøm J, Mehl R; GAIN. Cockroach sensitivity in Norway: a previously unidentified problem? Allergy 2002;57(6):529-33.
  76. Peng Z, Simons FE. Comparison of proteins, IgE, and IgG binding antigens, and skin reactivity in commercial and laboratory-made mosquito extracts. Ann Allergy Asthma Immunol 1996;77(5):371-6.
  77. Peng Z, Beckett AN, Wang Q, Simons FER. A comparison of the UniCap test with an ELISA in the diagnosis of individuals with systemic or severe local reactions to mosquito bites. J Allergy Clin Immunol 2003;111:S207.
  78. Tokura Y, Ishihara S, Tagawa S, Seo N, Ohshima K, Takigawa M. Hypersensitivity to mosquito bites as the primary clinical manifestation of a juvenile type of Epstein-Barr virus-associated natural killer cell leukemia/lymphoma. J Am Acad Dermatol 2001;45(4):569-78.
  79. Tokura Y, Tamura Y, Takigawa M, Koide M, Satoh T, Sakamoto T, Horiguchi D, Yamada M. Severe hypersensitivity to mosquito bites associated with natural killer cell lymphocytosis. Arch Dermatol 1990;126(3):362-8.
  80. Roshnee G, Cao GQ, Chen H. Hypersensitivity pneumonitis due to residential mosquito-coil smoke exposure. Chin Med J (Engl) 2011;124(12):1915-8.
  81. Vanden Driessche KS, Sow A, Van Gompel A, Vandeurzen K. Anaphylaxis in an airplane after insecticide spraying. J Travel Med 2010;17(6):427-9.


As in all diagnostic testing, the diagnosis is made by the physican based on both test results and the patient history.